The U.S. Food and Drug Administration (FDA) recently required the manufacturers of arthritis medications Xeljanz (tofacitinib) and Xeljanz XR (extended-release) to add new warnings to their medications. These warnings will alert doctors and patients to an increased risk of serious heart-related events such as heart…
Back in March 2020, the U.S. Food and Drug Administration (FDA) announced that it was strengthening the existing warnings about serious behavior and mood-related side effects associated with asthma medication Singulair (montelukast) and its generics. The drug already had warnings about mental health side effects,…
According to the results of a new study published in The FASEB Journal, Belviq (lorcaserin)—a weight-loss drug that was recalled from the market last year (2020)—could make opioid addiction problems worse. The U.S. Food and Drug Administration (FDA) requested the recall of Belviq and Belviq…
A New Jersey man recently filed a new Belviq lawsuit in the Superior Court of New Jersey against drug manufacturers Eisai Inc. and Arena Pharmaceuticals. He claims that after taking Belviq for weight loss, he suffered from serious injuries. What is Belviq? Belviq (lorcaserin hydrochloride)…
Hundreds of plaintiffs have filed Zantac lawsuits claiming that after years of using the heartburn drug, Zantac (ranitidine), they were diagnosed with bladder cancer. Now, a new study provides additional evidence to support their claims. The American Journal of Gastroenterology recently published research from Scotland…
A Florida woman and her husband recently filed a new Belviq lawsuit in the United States District Court for the Middle District of Florida. The plaintiff claims that after taking the weight-loss drug Belviq, she suffered from serious injuries. She seeks compensatory and punitive damages.…
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the recall of all forms of Zantac (ranitidine) from the market, due to concerns about cancer risks. This was the final step in over a year of investigations and studies on the drug…
Ever since a group of scientific studies came out connecting the interstitial cystitis drug Elmiron (pentosan polysulfate sodium or PPS) with eye and vision damage, patients have been filing Elmiron lawsuits in the hopes of recovering damages for their injuries. On December 15, 2020, the…
A Pennsylvania man recently filed a new Uloric lawsuit in the U.S. District Court for the Northern District of Illinois. He claims that after taking the prescription drug to treat his gout, he suffered from serious injuries. Plaintiff Prescribed Uloric to Treat His Gout According…
A Kentucky woman recently filed a new Elmiron lawsuit in the U.S. District Court for the District of New Jersey. She claims that after using the medication, she suffered from vision loss. Her case joins the other federally filed Elmiron lawsuits that were centralized in…
